Gillian Vandekerkhove

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

NeoBLAST: A Pilot Randomized Controlled Trial of Active Surveillance Versus Definitive Bladder Treatment Following Clinical Complete Response to Neoadjuvant Therapy in Muscle-invasive Bladder Cancer - Study Protocol.

NeoBLAST: A Pilot Randomized Controlled Trial of Active Surveillance Versus Definitive Bladder Treatment Following Clinical Complete Response to Neoadjuvant Therapy in Muscle-invasive Bladder Cancer - Study Protocol.

Journal: European urology oncology
Published: March 23, 2026

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

Journal: Nature communications
Published: October 09, 2025

Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer.

Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 26, 2025

Factors Affecting Genomic Testing in Prostate Cancer: Results From the Decision-Making, Experience, and Confidence In Determining Genomic Evaluation (DECIDE) Survey.

Factors Affecting Genomic Testing in Prostate Cancer: Results From the Decision-Making, Experience, and Confidence In Determining Genomic Evaluation (DECIDE) Survey.

Journal: JCO precision oncology
Published: May 15, 2025

Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.

Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis.

Journal: European urology oncology
Published: April 30, 2025

Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma.

Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma.

Journal: NPJ precision oncology
Published: January 17, 2025

ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer.

ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 21, 2024

Sensitive Detection of Urothelial Cancer via High-volume Urine DNA Analysis.

Sensitive Detection of Urothelial Cancer via High-volume Urine DNA Analysis.

Journal: European urology
Published: September 14, 2024

Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer.

Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer.

Journal: Cancer research
Published: June 20, 2024

Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer.

Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer.

Journal: JCO precision oncology
Published: March 28, 2024

A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes.

A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes.

Journal: NPJ precision oncology
Published: November 12, 2022

Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping.

Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping.

Journal: Nature cancer
Published: September 30, 2022
Showing 1-12 of 32

Last Updated: 09/26/2026